Scientists track cancer DNA in blood hours after treatment
NCT ID NCT06141772
Summary
This study aimed to understand when to best measure cancer DNA in the blood after lymphoma patients start chemotherapy. Researchers tracked 24 adults with diffuse large B-cell lymphoma right after their first treatment. The goal was to see if measuring DNA at a specific time could give doctors a clearer picture of the cancer than a standard pre-treatment test.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Henri Becquerel
Rouen, 76000, France
Conditions
Explore the condition pages connected to this study.